Clinic to Serve as rEEG(R) 'Center of Excellence' Advancing Performance in
Patient Outcomes, Costs and Convenience
COSTA MESA, Calif., Jan. 15 /PRNewswire-FirstCall/ -- CNS Response, Inc. (OTC Bulletin Board: CNSO) announced today that it has completed the previously announced acquisition of Neuro-Therapy Clinic, P.C., a neuropsychiatric clinic in Denver, Colorado. The Company also announced that Daniel A. Hoffman, MD has been appointed Chief Medical Officer. Dr. Hoffman, a neuropsychiatrist with more than 25 years experience, was previously National Medical Director of Neuro-Therapy Clinic.
Len Brandt, Chairman and CEO of CNS Response, reported, "Our close relationship with Dr. Hoffman and the Neurotherapy Clinic has already played a significant role in establishing the value of rEEG(R) guidance in medication management."
George Carpenter, President of CNS Response, commenting on the future, said, "We expect Neuro-Therapy Clinic to further define the opportunity to use technology in general, and rEEG in particular, to vastly improve clinic performance in patient outcomes, costs, and convenience and to best communicate this to all -- patient, physician, payer. In this way, the Neuro-Therapy Clinic is something of a dynamic laboratory discovering how to integrate technology and be a true center of excellence on all of these measures. Put to practice, this knowledge presents CNS Response with an opportunity to further our relationship with other clinics and physicians using rEEG."
"Dr. Hoffman is a leader and a true partner in the development of rEEG so we are particularly pleased to have him join our team," Mr. Brandt continued. "Dr. Hoffman will play a critical role in implementing our strategy for the validation and commercialization of our core rEEG platform."
Established in 1993, Neuro-Therapy Clinic, P.C. is a center for
highly-advanced testing and treatment of neuropsychiatric problems,
|SOURCE CNS Response, Inc.|
Copyright©2008 PR Newswire.
All rights reserved